Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targin in Korean Patients with Chemotherapy-Induced Peripheral Neuropathy
NCT01675531Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Mundipharma. Started Dec 2012; status: completed.
02
Drugs
oxycodone
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01675531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675531.